Search results
Results from the WOW.Com Content Network
(Reuters) -A Washington jury on Tuesday ordered Bayer to pay $100 million to four people who say they were sickened by toxic chemicals known as PCBs at a Seattle-area school, but found the company ...
The U.S. Department of Health & Human Services may seek over $1 billion from Johnson & Johnson as reimbursement for federal health agencies' payments of medical costs for patients who allege that ...
In 2020, Bayer settled most of the then-pending Roundup cases for up to $9.6 billion but failed to get a settlement covering future cases. More than 50,000 claims remain pending.
Johnson v. Monsanto Co. was the first lawsuit to proceed to trial over Monsanto 's Roundup herbicide product causing cancer. The lawsuit alleged that the exposure of glyphosate , an active ingredient in the Roundup product, caused Dewayne "Lee" Johnson's non-Hodgkin lymphoma .
Bayer. $10.9 billion German pharmaceutical company Bayer agreed to pay nearly $11 billion to settle thousands of lawsuits over subsidiary Monsanto’s weed-killer Roundup. The settlement aims to ...
Bayer and BASF were also ordered to pay Bader $15 million in damages. [135] On February 15, 2020, Monsanto and BASF were ordered to pay an additional $250 million in punitive damages. [136] [137] In June 2020, Bayer agreed to a settlement of up to $400 million for all 2015-2020 crop year dicamba claims, not including the $250 million judgement. [1]
In 2020, Bayer settled most of the then-pending Roundup cases for up to $9.6 billion but failed to get a settlement covering future cases. More than 50,000 claims remain pending.
The following are settlements reached with US authorities against pharmaceutical companies to resolve allegations of "off-label" promotion of drugs. Under the Federal Food, Drug, and Cosmetic Act, it is illegal for pharmaceutical companies to promote their products for uses not approved by the Food and Drug Administration (FDA), and corporations that market drugs for off-label indications may ...